SERINC5 and infection: SERINC5 had no effect on F-MLV infectivity even when glyco-Gag was mutated; however, it was only when we replaced the F-MLV envelope with the amphotropic MLV 4070A envelope that we found that SERINC5 restricted MLV infection in a glyco-Gag-dependent manner.